Prognostic Markers and Driver Genes and Options for Targeted Therapy in Human-Papillomavirus-Positive Tonsillar and Base-of-Tongue Squamous Cell Carcinoma

The incidence of Human-papillomavirus-positive (HPV(+)) tonsillar and base-of-tongue squamous cell carcinoma (TSCC and BOTSCC, respectively) is increasing epidemically, but they have better prognosis than equivalent HPV-negative (HPV(−)) cancers, with roughly 80% vs. 50% 3-year disease-free survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Näsman, Anders, Holzhauser, Stefan, Kostopoulou, Ourania N., Zupancic, Mark, Ährlund-Richter, Andreas, Du, Juan, Dalianis, Tina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156012/
https://www.ncbi.nlm.nih.gov/pubmed/34069114
http://dx.doi.org/10.3390/v13050910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156012/
https://www.ncbi.nlm.nih.gov/pubmed/34069114
http://dx.doi.org/10.3390/v13050910

Ejemplares similares